582 related articles for article (PubMed ID: 19631775)
1. Fibroblast growth factor 2-induced cytoplasmic asparaginyl-tRNA synthetase promotes survival of osteoblasts by regulating anti-apoptotic PI3K/Akt signaling.
Park SJ; Kim SH; Choi HS; Rhee Y; Lim SK
Bone; 2009 Nov; 45(5):994-1003. PubMed ID: 19631775
[TBL] [Abstract][Full Text] [Related]
2. Fidgetin-like 1 gene inhibited by basic fibroblast growth factor regulates the proliferation and differentiation of osteoblasts.
Park SJ; Kim SJ; Rhee Y; Byun JH; Kim SH; Kim MH; Lee EJ; Lim SK
J Bone Miner Res; 2007 Jun; 22(6):889-96. PubMed ID: 17352653
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
[TBL] [Abstract][Full Text] [Related]
4. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
Ando T; Ichikawa J; Wako M; Hatsushika K; Watanabe Y; Sakuma M; Tasaka K; Ogawa H; Hamada Y; Yagita H; Nakao A
Arthritis Res Ther; 2006; 8(5):R146. PubMed ID: 16945157
[TBL] [Abstract][Full Text] [Related]
5. Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways.
Tang SY; Xie H; Yuan LQ; Luo XH; Huang J; Cui RR; Zhou HD; Wu XP; Liao EY
Peptides; 2007 Mar; 28(3):708-18. PubMed ID: 17109997
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling.
Dufour C; Holy X; Marie PJ
Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E794-801. PubMed ID: 18378961
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 stimulates directed migration of periodontal ligament cells via PI3K/AKT signaling and CD44/hyaluronan interaction.
Shimabukuro Y; Terashima H; Takedachi M; Maeda K; Nakamura T; Sawada K; Kobashi M; Awata T; Oohara H; Kawahara T; Iwayama T; Hashikawa T; Yanagita M; Yamada S; Murakami S
J Cell Physiol; 2011 Mar; 226(3):809-21. PubMed ID: 20857427
[TBL] [Abstract][Full Text] [Related]
9. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
Carey GB; Semenova E; Qi X; Keegan AD
Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
[TBL] [Abstract][Full Text] [Related]
10. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway.
Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z
Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243
[TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase/Akt pathway regulates inflammatory mediators-induced calcification of human vascular smooth muscle cells.
Okazaki H; Shioi A; Hirowatari K; Koyama H; Fukumoto S; Ishimura E; Nishizawa Y
Osaka City Med J; 2009 Dec; 55(2):71-80. PubMed ID: 20088406
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells.
Li CF; Hughes-Fulford M
J Bone Miner Res; 2006 Jun; 21(6):946-55. PubMed ID: 16753025
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
14. Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2.
Song SJ; Cool SM; Nurcombe V
J Cell Biochem; 2007 Feb; 100(2):402-11. PubMed ID: 16924669
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
[TBL] [Abstract][Full Text] [Related]
16. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
17. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
19. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound stimulates cyclooxygenase-2 expression and increases bone formation through integrin, focal adhesion kinase, phosphatidylinositol 3-kinase, and Akt pathway in osteoblasts.
Tang CH; Yang RS; Huang TH; Lu DY; Chuang WJ; Huang TF; Fu WM
Mol Pharmacol; 2006 Jun; 69(6):2047-57. PubMed ID: 16540596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
